Pharyngitis Market

Pharyngitis Market Study by Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, and Tetracycline Sold at Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online from 2024 to 2034

Analysis of Pharyngitis Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Pharyngitis Market Outlook (2024 to 2034)

High levels of exposure to smoking, pollution, dry air, and various other environmental irritants such as strong fumes, allergens, etc., are directly damaging the pharyngeal tissues, which is driving up demand for effective pharyngitis treatment options. This has led to the global pharyngitis market size reaching a value of US$ 1.45 billion in 2024 and expected to increase to US$ 2.08 billion by 2034, expanding at a CAGR of 3.7% from 2024 to 2034.

In recent years, effective medications, including NSAIDs (non-steroidal anti-inflammatory drugs), antibiotics, antivirals, etc. have been adopted for the management of disease symptoms or treatment of ailments, which is further contributing to pharyngitis market growth. In addition, the inflating application of throat sprays or lozenges, containing numbing agents, menthol and lozenges, to relieve pain and discomfort by soothing the irritated tissues, is further contributing to the expansion of the pharyngitis market size.

Growing popularity of photobiomodulation therapy is attributed to its use of low-level lasers or light-emitting diodes to stimulate cellular function among patients. This therapy is also used to promote throat healing, thus driving opportunities for global market players.

  • Western Europe is projected to account for 17.6% share of the global market by 2034-end.
  • Demand for pharyngitis treatment products in Japan is expected to increase at a CAGR of 1.3% from 2024 to 2034.
  • Worldwide sales of beta-lactams are projected to increase at a CAGR of 3.7% and reach US$ 776.3 million by the end of 2034.

Growing preference for novel therapeutics, rising adoption of personalized medications, and increasing incidences of clinical trials are contributing to the demand for pharyngitis treatment solutions. Moreover, constant advancements in treatment methods and inclination to OTC (Over-the-counter) medicines are also estimated to positively influence pharyngitis market trends across regions in the coming 10 years.

Report Attributes Details
Pharyngitis Market Size (2024E) US$ 1.45 Billion
Forecasted Market Value (2034F) US$ 2.08 Billion
Global Market Growth Rate (2024 to 2034) 3.7% CAGR
Market Share of Retail Pharmacies & Drug Stores (2034F) 58.5%
South Korea Market Growth (2024 to 2034) 4.4% CAGR
South Asia & Pacific Market Share (2034F) 21.9%
Key Companies Profiled
  • Pfizer Inc.
  • Novartis AG
  • GlaxoSmithKline PLC
  • Zambon Group SpA.
  • BioStar Pharmaceuticals Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What’s Shaping the Market for Pharyngitis Treatment?

“Growing Demand for OTC Medicines”

An increase in the demand for OTC medications is encountered, which is projected to positively influence the demand for pharyngitis treatment options. There are various types of OTC pharyngitis medications, such as sprays, pain relievers, throat lozenges, multiple types of drugs, etc., readily available in convenience stores, hospitals, supermarkets, and online and retail pharmacies.

More patients are purchasing OTC products that too without any visit to a clinic or hospital or prescription, therefore making them more convenient for immediate symptom relief. The ability of OTC medications to offer relief for common symptoms, such as sore throat, discomfort, etc. is driving opportunities for players.

“Rising Preference for Novel Therapeutics”

In recent years, an increased demand for novel therapeutics has been encountered across regions. Present market available therapeutics and treatments are used widely, especially antibiotics. The constant involvement of manufacturers in novel therapeutics with better patient outcomes is estimated to result in minimal side effects to human beings. Therefore, a positive impact on market growth is encountered.

What Restraints are Limiting Demand Growth for Pharyngitis Treatment Options?

“Side Effects of Antibiotics and Availability of Alternative Treatment Options”

There are certain moderate side effects associated with the consumption of antibiotics used against pharyngitis. Some of these side effects are rashes, diarrhea, dizziness, and some other adverse effects encountered by patients consuming antibiotics.

Easy availability of alternative treatment is adversely impacting demand for pharyngitis treatment products. More pharyngitis patients are inclined to natural remedies, including ginger, honey, herbal products, including herbal tea, etc. to avoid the side effects of drugs.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

How Lucrative Will the Global Market Be for Startups?

“Offering Customized Pharyngitis Treatment Solutions”

Aspiring market players are expected to focus more on the development of medications according to clinical requirements as well as matching individual needs. These new entrants are anticipated to offer products with minimum side effects to help in rapid healing while causing minimal harm to the human body. Thus, these initiatives are estimated to help players secure a position for themselves while ensuring the utmost comfort to patients.

Country-wise Insights

With favorable reimbursement policies and advanced healthcare infrastructure, North America is anticipated to account for 35.9% share of the global market by the end of 2034.

Why is the United States a Highly Lucrative Market?

“Market Expansion Complemented by Presence of Well-established Healthcare Infrastructure”

Attribute United States
Market Value (2024E) US$ 453.3 Million
Growth Rate (2024 to 2034) 4% CAGR
Projected Value (2034F) US$ 673.1 Million

With the presence of well-established and advanced healthcare infrastructure, such as specialty clinics, hospitals, ENT clinics, and others, the United States is estimated to hold 86.8% share of the North American market by the end of 2034. These healthcare institutes offer better therapeutics and treatment facilities for quick relief from pharyngitis. Further, an increase in the cases of pharyngitis is set to generate demand for effective therapeutics, which contribute to improved patient outcomes. The availability of supportive healthcare insurance facilities and reimbursement policies is expected to positively impact demand for pharyngitis treatment services in the country.

Why is There an Increase in Demand for Pharyngitis Treatment Products in China?

“Growing Expenditure on R&D Activities to Offer Advanced Healthcare Facilities”

Attribute China
Market Value (2024E) US$ 109.2 Million
Growth Rate (2024 to 2034) 5.4% CAGR
Projected Value (2034F) US$ 184.6 Million

Increasing investments in advanced healthcare facilities in China is set to help the country account for 50.9% share of the market in East Asia by the end of 2034. Healthcare providers are now able to offer more efficient pharyngitis treatment solutions to patients to improve the issues and symptoms related to throat infections.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Insights

Fact.MR, a market research and competitive intelligence provider, in its recently updated report, asserts that demand for pharyngitis treatment products through retail pharmacies and drug stores is projected to increase at a CAGR of 3.9% and reach a value of US$ 1.22 billion by the end of 2034. Issues related to sore throats are very common, therefore pharmacists assess particular symptoms as mentioned by patients. In addition, the introduction of novel products by pharmaceutical companies is projected to help respective patients get rapid relief from pain.

Which Drug Class is More Preferred in the This Market?

“Rising Use of Beta Lactams as Commonly Preferred Drug”

Attribute Beta Lactams
Segment Value (2024E) US$ 540.8 Million
Growth Rate (2024 to 2034) 3.7% CAGR
Projected Value (2034F) US$ 776.3 Million

Beta lactams are anticipated to hold 37.2% of the pharyngitis market share by the end of the assessment period in 2034. Beta lactams are set to emerge as one of the commonly preferred drug classes over other options. Penicillins and cephalosporins are included in beta-lactams. These drugs are used as effective solutions against numerous harmful organisms. Further, recent developments taking place for the production of broad-spectrum beta-lactam antibiotics, which are used actively against gram-negative organisms are increasing their use.

What Mode of Drug Delivery is Common for Pharyngitis Treatment?

“High Use of Oral Delivery Mode Due to Convenience and Cost-effectiveness”

Attribute Oral Delivery Mode
Segment Value (2024E) US$ 619.8 Million
Growth Rate (2024 to 2034) 3.6% CAGR
Projected Value (2034F) US$ 879.7 Million

The oral drug delivery mode is approximated to account for 42.2% share of the global market by the end of 2034. High patient compliance, convenience, and cost-effectiveness are key features of this oral drug delivery mode, which are attracting more patients.

Competitive Landscape

Increasing use of advanced healthcare technologies ensures more efficient facilities, which is further generating lucrative opportunities for providers of pharyngitis treatment solutions. Thus, the incorporation of various strategies, including mergers, maintaining product quality control, new product development, acquisitions, and supplying quality healthcare products, helps players to get a competitive edge.

Pfizer Inc., Novartis AG, GlaxoSmithKline PLC, Zambon Group SpA., and BioStar Pharmaceuticals Inc. are key players in the pharyngitis market.

Segmentation of Pharyngitis Market Research

  • By Drug Class :

    • Beta Lactams
    • Macrolides
    • Cephalosporins
    • Fluoroquinolones
    • Tetracycline
    • Reusable
  • By Mode of Delivery :

    • Oral
    • Intravenous
    • Intramuscular
  • By Distribution Channel :

    • Hospital Pharmacies
    • Retail Pharmacies & Drug Stores
    • Online Pharmacies
  • By Region :

    • North America
    • Europe
    • East Asia
    • Latin America
    • Middle East & Africa
    • South Asia & Oceania

- FAQs -

What is the value of the pharyngitis market in 2024?

The global pharyngitis market is calculated at US$ 1.45 billion in 2024.

How big is the size of the global market expected to be by 2034?

Worldwide demand for pharyngitis treatment products is projected to reach a valuation of US$ 2.08 billion by 2034.

At what rate is the demand for pharyngitis treatment products projected to increase?

The market for pharyngitis is projected to expand at a CAGR of 3.7% from 2024 to 2034.

What is the expected contribution of North America to global market revenue?

North America is approximated to account for 35.9% share of global market revenue by 2034.

What is the market scenario for the oral delivery mode?

Revenue from oral pharyngitis treatment products is evaluated to reach US$ 879.7 million by 2034.

At what CAGR is the demand for pharyngitis treatment products estimated to increase in South Korea?

Sales of pharyngitis treatment products in South Korea are forecasted to rise at a CAGR of 4.4% from 2024 to 2034.

- Also of Interest -

Throat Lozenges Market

Throat Lozenges Market Study by Hard Candy Lozenges, Soft Lozenges, and Compressed Lozenges for Sore Throat, Cough & Cold, and Throat Diseases from 2024 to 2034

OTC Cough, Cold and Allergy Medicine Market

OTC Cough, Cold and Allergy Medicine Market Forecast by Drug Type (Antihistamine, Expectorants, Bronchodilators, and Antibiotics), by OTC Channel (Pharmacies, Drug Store, Modern Trade Online Sales), by Dosage (Capsules, Liquid, Lozenges), by Application, and by Region - 2022 to 2032

Natural Cold, Cough, and Sore Throat Remedies Market

Natural Cold, Cough, and Sore Throat Remedies Market Study by Syrups & Drops, Tablets & Capsules, and Lozenges for Hospital Pharmacies, Retail Pharmacies, and e-Commerce from 2023 to 2033

Pharyngitis Market

Schedule a Call